RUNX1通过ACP5/SMAD3介导的M2巨细胞极化促进NSCLC的进展
Changjun He1, Yingbin Li2, Nianyu Gao3
1Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150086, Heilongjiang, China. ChangjunHe1209@163.com.
概括
RUNX1通过通过ACP5和β-catenin增强M2巨分极,从而促进肺癌的进展,从而导致SMAD3酸化的增加. 抑制RUNX1抑制了小鼠的瘤生长.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 与瘤相关的巨细胞 (TAMs) 在瘤微环境中起着至关重要的作用.
- 大细胞两极分化,特别是M2两极分化,与癌症的进展和免疫逃避有关.
- 转录因子RUNX1 (与Runt相关的转录因子1) 已与各种癌症有关,但其在调节肺癌中TAMs的具体作用尚不清楚.
研究的目的:
- 研究RUNX1调节肺癌中瘤相关巨细胞 (TAMs) M2极化机制.
- 阐明涉及RUNX1-介导的巨细胞两极化及其对非小细胞肺癌 (NSCLC) 进展的影响下游信号通路.
主要方法:
- 骨髓衍生巨细胞 (BMDMs) 用瘤条件介质 (CM) 进行刺激,并用RUNX1shRNA,pCDNA3.1-ACP5或SIS3.3.5进行治疗.
- 使用流式细胞计和ELISA分析了巨分极和细胞因子分泌.
- 评估了RUNX1,ACP5,p-β-catenin,β-catenin和p-SMAD3中的蛋白质水平. 通过共同免疫沉 (Co-IP) 证实了ACP5和β-catenin之间的相互作用.
- 共同培养系统 (Transwell) 和体内小鼠模型 (路易斯肺癌) 用于评估对癌细胞恶性和瘤生长的影响.
主要成果:
- 瘤CM诱导了BMDM中的M2极化,M2型巨细胞中RUNX1表达上调.
- RUNX1 knockdown 将巨细胞转移到M1偏向,减少M2标记物,并抑制NSCLC细胞恶性病变.
- 通过增强ACP5-β-catenin相互作用,RUNX1促进了M2极化和NSCLC的进展,导致SMAD3酸化的增加. 在体内,RUNX1敲击抑制了M2极化和瘤生长.
结论:
- 在肺癌的瘤微环境中,RUNX1驱动着巨细胞的M2极化.
- 这一过程通过促进ACP5和β-catenin之间的相互作用来调解,随后增加SMAD3的酸化.
- RUNX1诱导的M2极化有助于非小细胞肺癌 (NSCLC) 的进展,突出了RUNX1作为潜在的治疗点.
更多相关视频
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
31.1K
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
412
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
